NCT07249619Not yet recruiting
A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in ICU
A Biopsychosocial-Based Multimodal Approach to Reducing the Risk of Delirium in Patients With Subarachnoid Hemorrhage in the Intensive Care Unit (ICU.Delibma)
Source: ClinicalTrials.gov · Last updated 25 Nov 2025
Brief summary (registry, in English)
As part of this study, an intervention program aimed at preventing delirium in patients with subarachnoid hemorrhage treated in the intensive care unit will be implemented. Routine medical treatments, environmental adjustments, and a video-based communication program will be implemented to prevent delirium. In addition, basic body awareness training will be administered. Patients will be divided into two groups. One group will receive only the routine treatment program recommended by international guidelines (medical, enviromental adjustment and face-to-face interview etc.), while the other group will receive body awareness therapy addition to routine interventions.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- First submitted
- 18 Nov 2025
- Start date
- 2 Jan 2026
- Primary completion date
- 2 Jan 2028
- Lead sponsor
- Emre Şenocak
- Diseases
- Stroke
- NCT number
- NCT07249619
What you commit to
- Study type: Interventional
- Planned participants: 34
- From 2 Jan 2026 to the primary completion date, 2 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Terminal cancer cases;
- Patients with advanced chronic heart and lung failure and COPD;
- Those with a history of dementia, Alzheimer's disease, or psychiatric illness;
- Those with a history of epilepsy;
Other
- Patients whose GCS fell to 14 or below for any reason during the study period;
- Patients who developed septic shock and MODS;
- Patients requiring endotrachial intubation and mechanical ventilation due to ARDS;
- Those requiring vasopressors such as NE at a rate of \>0.25 mcg/kg/min;
- Those with a METS (exercise capacity) of \<4;
- Those with vision, hearing, or speech problems that would interfere with communication;
Who the study is looking for
- Aged 18-85,
- Patients scheduled for intensive care for at least 15 days due to SAH, unruptured intracranial aneurysm, and/or Arterovenous Malformation,
- Those with a Mini Mental State Examination score of \> 24,
- Those with a Glasgow Coma Score of 15,
- Those with motor function in at least one extremity,
- Those with pain \< 5/10 (according to the NRS)
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karadeniz Technical University Farabi Hospital Coordinator of this site? Confirm its status | Trabzon | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.